HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC. Research Abstract Details
Jump to the:
J A Ellerhorst,W H Hildebrand,J W Cavett,M A Fernandez-Vina,S Hodges,N Poindexter,H Fischer,E A Grimm,
JA Ellerhorst,WH Hildebrand,JW Cavett,MA Fernandez-Vina,S Hodges,N Poindexter,H Fischer,EA Grimm,
For similar abstracts research abstracts see: abstracts research
PUBMED ID PMID:
MEDLINE DATE:
PUBLICATION TYPE: Journal Article
Journal: Der Urologe. Ausg. A
VOLUME: 43 Suppl 3
Page Numbers: 137
Journal Abbreviation:
ISSN: 0340-2592
DAY: 14
MONTH: Sep
YEAR: 2004
Number of References:
LANGUAGE: eng
NlmUniqueID: 1304110
KEYWORDS:
MESH TERMS:
Substance Name:
Registry Number:
AFFILIATION: The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA, jaellerh@mail.mdanderson.com
Country: Germany
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Urologe A
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!
Already registered? Login now below.
Already registered and Forgot your password? Click below to recover it.
Recover Lost Password
Join now - it's fast and free!
Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!
For more click here:Science News